These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12471194)

  • 21. Diagnosis and treatment of paradoxical embolus.
    Travis JA; Fuller SB; Ligush J; Plonk GW; Geary RL; Hansen KJ
    J Vasc Surg; 2001 Nov; 34(5):860-5. PubMed ID: 11700487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare case of pulmonary arteriovenous fistula simulating residual defect after transcatheter closure of patent foramen ovale for recurrent paradoxical embolism.
    Peters B; Ewert P; Schubert S; Abdul-Khaliq H; Lange PE
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):348-51. PubMed ID: 15736259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous closure of patent foramen ovale guided by intracardiac echocardiography and performed through the transfemoral approach in the presence of previously placed inferior vena cava filters: a case series.
    Awadalla H; Boccalandro F; Majano RA; Moustapha A; Salloum JG; Smalling RW
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):242-6. PubMed ID: 15390345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.
    Windecker S; Wahl A; Chatterjee T; Garachemani A; Eberli FR; Seiler C; Meier B
    Circulation; 2000 Feb; 101(8):893-8. PubMed ID: 10694529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical embolism causing acute embolic events in a patient with hereditary thrombophilia.
    Tang L; Fang ZF; Zhou SH
    Herz; 2015 Apr; 40(2):314-7. PubMed ID: 24154889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of thrombolytic therapy in the management of paradoxical embolism.
    d'Audiffret A; Shenoy SS; Ricotta JJ; Dryjski M
    Cardiovasc Surg; 1998 Jun; 6(3):302-6. PubMed ID: 9705104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Septic paradoxical embolus through a patent foramen ovale after pacemaker implantation.
    Allie DE; Lirtzman MD; Wyatt CH; Vitrella DA; Walker CM
    Ann Thorac Surg; 2000 Mar; 69(3):946-8. PubMed ID: 10750797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caught in the act: impending paradoxical embolism.
    Fabricius AM; Krüger M; Hanke M; Mohr FW
    Asian Cardiovasc Thorac Ann; 2002 Dec; 10(4):342-3. PubMed ID: 12538283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.
    Khairy P; O'Donnell CP; Landzberg MJ
    Ann Intern Med; 2003 Nov; 139(9):753-60. PubMed ID: 14597460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of recurrent stroke and pulmonary thromboembolism with percutaneous closure of a patent foramen ovale and placement of inferior vena cava filter.
    Donti A; Giardini A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Picchio FM
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):413-5. PubMed ID: 12594715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of paradoxical embolism and patent formen ovale.
    Mas JL
    Curr Opin Cardiol; 1996 Sep; 11(5):519-24. PubMed ID: 8889379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous occlusion of patent foramen ovale in patients with paradoxical embolism.
    Pinto FF; Sousa L; Abreu J; Agapito A; Quininha J; Kaku S; Antunes AM
    Rev Port Cardiol; 2001; 20(7-8):747-57; discussion 759-62. PubMed ID: 11582625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paradoxical embolism: Myth or reality?].
    Aubry P; Demian H; Brochet E; Juliard JM
    Ann Cardiol Angeiol (Paris); 2017 Dec; 66(6):433-440. PubMed ID: 29096902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent cardiac foramen ovale: stroke risk and closure.
    Mohr JP; Homma S
    Ann Intern Med; 2003 Nov; 139(9):787-8. PubMed ID: 14597465
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism.
    Ende DJ; Chopra PS; Rao PS
    Am J Cardiol; 1996 Jul; 78(2):233-6. PubMed ID: 8712152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
    J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracardiac migration of nitinol TrapEase vena cava filter and paradoxical embolism.
    Porcellini M; Stassano P; Musumeci A; Bracale G
    Eur J Cardiothorac Surg; 2002 Sep; 22(3):460-1. PubMed ID: 12204746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical embolization in an adult cystic fibrosis patient.
    Al Lawati NM; Wilcox P
    Can Respir J; 2007; 14(5):293-4. PubMed ID: 17703245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.